A little over a year ago, in
July, 2012, a Stryker recall was issued for the Rejuvenate and ABGII hip
implant devices. These implants fell under a Stryker recall due to the risks of
fretting and corrosion which could lead to the release of metal ions into the
body and failure of the hip implant. When a hip implant fails, revision surgery
becomes necessary—an expensive and potentially risky procedure. Nearly 20,000
people were implanted with a Rejuvenate or ABGII hip device prior to the
Stryker recall. These people hoped to have the quality of their life improved
through being able to achieve greater mobility. When the Stryker recall was issued,
the hopes of many of those people were dashed.
Of course prior to the Stryker
recall, many recipients had already suffered serious adverse health effects
from their Stryker hip. Stryker advertised this innovative new design as
potentially lasting 15-20 years, saving many people from ever having to have
their hip implant replaced. Unfortunately, following the Stryker recall, most
recipients realized they would likely not have their Stryker hip implant
anywhere close to that long. In fact, at the time of the Stryker recall, the
company refused to put a number on the risk of failure, but later, independent
studies placed that risk as high as 40%. What this meant for those subject to the
Stryker recall, is that those patients who had not yet had trouble with their
implant likely would in the near
future.
No comments:
Post a Comment